Skip to main content
Top
Published in: Breast Cancer 1/2017

01-01-2017 | Special Feature

Possible supplemental breast cancer screening modalities

Author: Takayoshi Uematsu

Published in: Breast Cancer | Issue 1/2017

Login to get access

Excerpt

Mammography is the only screening modality that has been proven to reduce breast cancer mortality, apart from access to therapy; however, it is not the perfect screening modality for women with dense breasts. Although digital mammography has been shown to be more sensitive than film-screen mammography for women with dense breasts, there is a scope for improvement. Supplemental breast cancer screening modalities have been proposed to increase the sensitivity and detection rates of early-stage breast cancer in women with dense breasts. However, there are no global guidelines that recommend the use of supplemental breast cancer screening modalities in such women. Therefore, we need to know the current status and clinical pathways regarding possible supplemental breast cancer screening modalities for women with dense breasts. …
Literature
Metadata
Title
Possible supplemental breast cancer screening modalities
Author
Takayoshi Uematsu
Publication date
01-01-2017
Publisher
Springer Japan
Published in
Breast Cancer / Issue 1/2017
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-016-0727-y

Other articles of this Issue 1/2017

Breast Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine